{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:35:08Z","timestamp":1779327308740,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"crossref","award":["310030_152912\/1"],"award-info":[{"award-number":["310030_152912\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"crossref","award":["K0001"],"award-info":[{"award-number":["K0001"]}],"id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anti-apolipoprotein A-1 (anti-apoA-1 IgG) and anti-double stranded DNA (anti-dsDNA IgG) autoantibodies have been described as mediators of atherogenesis in mice and humans. In the present study, we aim to investigate the association between atherosclerotic parameters, autoantibodies and plaque vulnerability in the context of systemic lupus erythematosus (SLE). We therefore bred a lupus prone-mouse model (Nba2.<jats:italic>Yaa<\/jats:italic> mice) with Apoe<jats:sup>\u2212\/\u2212<\/jats:sup> mice resulting in Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> mice spontaneously producing anti-apoA-1 IgG antibodies. Although Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> and Apoe<jats:sup>\u2212\/\u2212<\/jats:sup> mice subject to a high cholesterol diet displayed similar atherosclerosis lesions size in aortic roots and abdominal aorta, the levels of macrophage and neutrophil infiltration<jats:bold>,<\/jats:bold> collagen, MMP-8 and MMP-9 and pro-MMP-9 expression in Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> mice indicated features of atherosclerotic plaque vulnerability. Even though Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> mice and Apoe<jats:sup>\u2212\/\u2212<\/jats:sup> mice had similar lipid levels, Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> mice showed higher anti-apoA-1 and anti-dsDNA IgG levels. Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> mice displayed a reduction of the size of the kidney, splenomegaly and lymph nodes (LN) hypertrophy. In addition, anti-apoA-1 and anti-dsDNA IgG increased also in relation with mRNA levels of GATA3, IL-4, Bcl-6 and CD20 in the spleen and aortic arch of Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> mice. Our data show that although atherosclerosis-lupus-prone Apoe<jats:sup>\u2212\/\u2212<\/jats:sup>Nba2.<jats:italic>Yaa<\/jats:italic> mice did not exhibit exacerbated atherosclerotic lesion size, they did show features of atherosclerotic plaque destabilization in correlation with the increase of pro-atherogenic autoantibodies.<\/jats:p>","DOI":"10.1038\/s41598-020-74579-8","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:03:40Z","timestamp":1603796620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Atherosclerotic plaque vulnerability is increased in mouse model of lupus"],"prefix":"10.1038","volume":"10","author":[{"given":"Marie-Laure","family":"Santiago-Raber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-8729","authenticated-orcid":false,"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Vuilleumier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapka","family":"Miteva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-4078","authenticated-orcid":false,"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1042-5283","authenticated-orcid":false,"given":"Karim J.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"74579_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","volume":"11","author":"MT Nurmohamed","year":"2015","unstructured":"Nurmohamed, M. T., Heslinga, M. & Kitas, G. D. Cardiovascular comorbidity in rheumatic diseases. Nat. Rev. Rheumatol. 11, 693\u2013704. https:\/\/doi.org\/10.1038\/nrrheum.2015.112 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"74579_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","volume":"36","author":"JC Mason","year":"2015","unstructured":"Mason, J. C. & Libby, P. Cardiovascular disease in patients with chronic inflammation: Mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur. Heart. J. 36, 482\u2013489c. https:\/\/doi.org\/10.1093\/eurheartj\/ehu403 (2015).","journal-title":"Eur. Heart. J."},{"key":"74579_CR3","doi-asserted-by":"publisher","first-page":"e0185889","DOI":"10.1371\/journal.pone.0185889","volume":"12","author":"PP Perrotti","year":"2017","unstructured":"Perrotti, P. P. et al. Genetic variation associated with cardiovascular risk in autoimmune diseases. PLoS ONE 12, e0185889. https:\/\/doi.org\/10.1371\/journal.pone.0185889 (2017).","journal-title":"PLoS ONE"},{"key":"74579_CR4","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","volume":"114","author":"P Libby","year":"2014","unstructured":"Libby, P., Tabas, I., Fredman, G. & Fisher, E. A. Inflammation and its resolution as determinants of acute coronary syndromes. Circ. Res. 114, 1867\u20131879. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302699 (2014).","journal-title":"Circ. Res."},{"key":"74579_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","volume":"12","author":"GK Hansson","year":"2011","unstructured":"Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat. Immunol. 12, 204\u2013212. https:\/\/doi.org\/10.1038\/ni.2001 (2011).","journal-title":"Nat. Immunol."},{"key":"74579_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2174\/1389450115666141125122416","volume":"16","author":"N Satta","year":"2015","unstructured":"Satta, N. & Vuilleumier, N. Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies. Curr.. Drug Targets 16, 342\u2013360. https:\/\/doi.org\/10.2174\/1389450115666141125122416 (2015).","journal-title":"Curr.. Drug Targets"},{"key":"74579_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/MOL.0b013e32834adaf3","volume":"22","author":"T Kyaw","year":"2011","unstructured":"Kyaw, T., Tipping, P., Toh, B. H. & Bobik, A. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr. Opin. Lipidol. 22, 373\u2013379. https:\/\/doi.org\/10.1097\/MOL.0b013e32834adaf3 (2011).","journal-title":"Curr. Opin. Lipidol."},{"key":"74579_CR8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","volume":"114","author":"D Tsiantoulas","year":"2014","unstructured":"Tsiantoulas, D., Diehl, C. J., Witztum, J. L. & Binder, C. J. B cells and humoral immunity in atherosclerosis. Circ. Res. 114, 1743\u20131756. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301145 (2014).","journal-title":"Circ. Res."},{"key":"74579_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity 41, 529\u2013542. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.004 (2014).","journal-title":"Immunity"},{"key":"74579_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2016.10.017","volume":"173","author":"X Huang","year":"2016","unstructured":"Huang, X. et al. The expression of Bcl-6 in circulating follicular helper-like T cells positively correlates with the disease activity in systemic lupus erythematosus. Clin. Immunol. 173, 161\u2013170. https:\/\/doi.org\/10.1016\/j.clim.2016.10.017 (2016).","journal-title":"Clin. Immunol."},{"key":"74579_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa069","author":"F Burger","year":"2020","unstructured":"Burger, F. et al. Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvaa069 (2020).","journal-title":"Cardiovasc. Res."},{"key":"74579_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1191\/096120398678920262","volume":"7","author":"AR Dinu","year":"1998","unstructured":"Dinu, A. R. et al. Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. Lupus 7, 355\u2013360. https:\/\/doi.org\/10.1191\/096120398678920262 (1998).","journal-title":"Lupus"},{"key":"74579_CR13","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1002\/art.27546","volume":"62","author":"N Vuilleumier","year":"2010","unstructured":"Vuilleumier, N. et al. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 62, 2640\u20132650. https:\/\/doi.org\/10.1002\/art.27546 (2010).","journal-title":"Arthritis Rheum."},{"key":"74579_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1160\/TH12-10-0714","volume":"109","author":"N Vuilleumier","year":"2013","unstructured":"Vuilleumier, N. et al. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy. Thromb. Haemost. 109, 706\u2013715. https:\/\/doi.org\/10.1160\/TH12-10-0714 (2013).","journal-title":"Thromb. Haemost."},{"key":"74579_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/eurheartj\/ehq055","volume":"31","author":"N Vuilleumier","year":"2010","unstructured":"Vuilleumier, N. et al. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. Eur. Heart J. 31, 815\u2013823. https:\/\/doi.org\/10.1093\/eurheartj\/ehq055 (2010).","journal-title":"Eur. Heart J."},{"key":"74579_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jdiacomp.2016.02.014","volume":"30","author":"D El-Lebedy","year":"2016","unstructured":"El-Lebedy, D. et al. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus. J. Diabetes Complications 30, 580\u2013585. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.02.014 (2016).","journal-title":"J. Diabetes Complications"},{"key":"74579_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrrheum.2014.6","volume":"10","author":"KD Deane","year":"2014","unstructured":"Deane, K. D. & El-Gabalawy, H. Pathogenesis and prevention of rheumatic disease: Focus on preclinical RA and SLE. Nat. Rev. Rheumatol. 10, 212\u2013228. https:\/\/doi.org\/10.1038\/nrrheum.2014.6 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"74579_CR18","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/j.jacc.2015.03.578","volume":"65","author":"EB Solow","year":"2015","unstructured":"Solow, E. B. et al. Antinuclear antibodies are associated with all-cause mortality and cardiovascular outcomes in the general population. J. Am. Coll. Cardiol. 65, 2669\u20132670. https:\/\/doi.org\/10.1016\/j.jacc.2015.03.578 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"74579_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1160\/TH14-12-1039","volume":"114","author":"F Montecucco","year":"2015","unstructured":"Montecucco, F. et al. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4. Thromb. Haemost. 114, 410\u2013422. https:\/\/doi.org\/10.1160\/TH14-12-1039 (2015).","journal-title":"Thromb. Haemost."},{"key":"74579_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1160\/TH16-03-0229","volume":"116","author":"S Pagano","year":"2016","unstructured":"Pagano, S. et al. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis. Thromb. Haemost. 116, 554\u2013564. https:\/\/doi.org\/10.1160\/TH16-03-0229 (2016).","journal-title":"Thromb. Haemost."},{"key":"74579_CR21","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1210\/en.2015-1605","volume":"156","author":"T Mannic","year":"2015","unstructured":"Mannic, T. et al. CD14 as a mediator of the mineralocorticoid receptor-dependent anti-apolipoprotein A-1 IgG chronotropic effect on cardiomyocytes. Endocrinology 156, 4707\u20134719. https:\/\/doi.org\/10.1210\/en.2015-1605 (2015).","journal-title":"Endocrinology"},{"key":"74579_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-2796.2012.02530.x","volume":"272","author":"S Pagano","year":"2012","unstructured":"Pagano, S. et al. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2\/CD14 complex. J. Intern. Med. 272, 344\u2013357. https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02530.x (2012).","journal-title":"J. Intern. Med."},{"key":"74579_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jaut.2004.08.003","volume":"23","author":"N Vuilleumier","year":"2004","unstructured":"Vuilleumier, N. et al. Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease. J Autoimmun 23, 353\u2013360. https:\/\/doi.org\/10.1016\/j.jaut.2004.08.003 (2004).","journal-title":"J Autoimmun"},{"key":"74579_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4049\/jimmunol.174.2.1111","volume":"174","author":"S Kikuchi","year":"2005","unstructured":"Kikuchi, S. et al. Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis. J. Immunol. 174, 1111\u20131117. https:\/\/doi.org\/10.4049\/jimmunol.174.2.1111 (2005).","journal-title":"J. Immunol."},{"key":"74579_CR25","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1126\/science.1124978","volume":"312","author":"P Pisitkun","year":"2006","unstructured":"Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669\u20131672. https:\/\/doi.org\/10.1126\/science.1124978 (2006).","journal-title":"Science"},{"key":"74579_CR26","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.4049\/jimmunol.176.5.3240","volume":"176","author":"S Kikuchi","year":"2006","unstructured":"Kikuchi, S. et al. Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus. J. Immunol. 176, 3240\u20133247. https:\/\/doi.org\/10.4049\/jimmunol.176.5.3240 (2006).","journal-title":"J. Immunol."},{"key":"74579_CR27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jvs.2013.03.048","volume":"59","author":"M Hakimi","year":"2014","unstructured":"Hakimi, M., Peters, A., Becker, A., Bockler, D. & Dihlmann, S. Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis. J. Vasc. Surg. 59, 794\u2013803. https:\/\/doi.org\/10.1016\/j.jvs.2013.03.048 (2014).","journal-title":"J. Vasc. Surg."},{"key":"74579_CR28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","volume":"33","author":"JI Borissoff","year":"2013","unstructured":"Borissoff, J. I. et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler. Thromb. Vasc. Biol. 33, 2032\u20132040. https:\/\/doi.org\/10.1161\/ATVBAHA.113.301627 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"74579_CR29","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","volume":"125","author":"Y Doring","year":"2012","unstructured":"Doring, Y. et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 125, 1673\u20131683. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.046755 (2012).","journal-title":"Circulation"},{"key":"74579_CR30","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/art.21955","volume":"54","author":"S Bernatsky","year":"2006","unstructured":"Bernatsky, S. et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 54, 2550\u20132557. https:\/\/doi.org\/10.1002\/art.21955 (2006).","journal-title":"Arthritis Rheum."},{"key":"74579_CR31","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3899\/jrheum.161121","volume":"44","author":"K Tselios","year":"2017","unstructured":"Tselios, K., Gladman, D. D., Su, J., Ace, O. & Urowitz, M. B. Evolution of risk factors for atherosclerotic cardiovascular events in systemic lupus erythematosus: A longterm prospective study. J. Rheumatol. 44, 1841\u20131849. https:\/\/doi.org\/10.3899\/jrheum.161121 (2017).","journal-title":"J. Rheumatol."},{"key":"74579_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","volume":"145","author":"S Manzi","year":"1997","unstructured":"Manzi, S. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am. J. Epidemiol. 145, 408\u2013415. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009122 (1997).","journal-title":"Am. J. Epidemiol."},{"key":"74579_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.4330\/wjc.v6.i5.314","volume":"6","author":"N Vuilleumier","year":"2014","unstructured":"Vuilleumier, N., Montecucco, F. & Hartley, O. Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity. World J. Cardiol. 6, 314\u2013326. https:\/\/doi.org\/10.4330\/wjc.v6.i5.314 (2014).","journal-title":"World J. Cardiol."},{"key":"74579_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","volume":"12","author":"G Chinetti-Gbaguidi","year":"2015","unstructured":"Chinetti-Gbaguidi, G., Colin, S. & Staels, B. Macrophage subsets in atherosclerosis. Nat. Rev. Cardiol. 12, 10\u201317. https:\/\/doi.org\/10.1038\/nrcardio.2014.173 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"74579_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/acr.20365","volume":"63","author":"YH Rho","year":"2011","unstructured":"Rho, Y. H. et al. Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res. 63, 535\u2013541. https:\/\/doi.org\/10.1002\/acr.20365 (2011).","journal-title":"Arthritis Care Res."},{"key":"74579_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar3206","volume":"13","author":"WH Shao","year":"2011","unstructured":"Shao, W. H. & Cohen, P. L. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res. Ther. 13, 202. https:\/\/doi.org\/10.1186\/ar3206 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"74579_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1161\/ATVBAHA.119.312434","volume":"39","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Smooth muscle cells contribute the majority of foam cells in ApoE (Apolipoprotein E)-deficient mouse atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 39, 876\u2013887. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312434 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"74579_CR38","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/STROKEAHA.110.578369","volume":"41","author":"F Montecucco","year":"2010","unstructured":"Montecucco, F. et al. Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 41, 1394\u20131404. https:\/\/doi.org\/10.1161\/STROKEAHA.110.578369 (2010).","journal-title":"Stroke"},{"key":"74579_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/eurheartj\/ehr449","volume":"33","author":"F Montecucco","year":"2012","unstructured":"Montecucco, F. et al. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur. Heart J. 33, 846\u2013856. https:\/\/doi.org\/10.1093\/eurheartj\/ehr449 (2012).","journal-title":"Eur. Heart J."},{"key":"74579_CR40","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","volume":"349","author":"A Warnatsch","year":"2015","unstructured":"Warnatsch, A., Ioannou, M., Wang, Q. & Papayannopoulos, V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 349, 316\u2013320. https:\/\/doi.org\/10.1126\/science.aaa8064 (2015).","journal-title":"Science"},{"key":"74579_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2019.06.919","volume":"288","author":"IC Moschonas","year":"2019","unstructured":"Moschonas, I. C. & Tselepis, A. D. The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis. Atherosclerosis 288, 9\u201316. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.06.919 (2019).","journal-title":"Atherosclerosis"},{"key":"74579_CR42","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","volume":"184","author":"MF Denny","year":"2010","unstructured":"Denny, M. F. et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 184, 3284\u20133297. https:\/\/doi.org\/10.4049\/jimmunol.0902199 (2010).","journal-title":"J. Immunol."},{"key":"74579_CR43","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","volume":"187","author":"E Villanueva","year":"2011","unstructured":"Villanueva, E. et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187, 538\u2013552. https:\/\/doi.org\/10.4049\/jimmunol.1100450 (2011).","journal-title":"J. Immunol."},{"key":"74579_CR44","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/art.38703","volume":"66","author":"CK Smith","year":"2014","unstructured":"Smith, C. K. et al. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: An additional proatherogenic mechanism in systemic lupus erythematosus. Arthritis Rheumatol. 66, 2532\u20132544. https:\/\/doi.org\/10.1002\/art.38703 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"74579_CR45","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/art.11237","volume":"48","author":"Y Ren","year":"2003","unstructured":"Ren, Y. et al. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 48, 2888\u20132897. https:\/\/doi.org\/10.1002\/art.11237 (2003).","journal-title":"Arthritis Rheum."},{"key":"74579_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00296-006-0219-z","volume":"27","author":"DJ Armstrong","year":"2006","unstructured":"Armstrong, D. J., Crockard, A. D., Wisdom, B. G., Whitehead, E. M. & Bell, A. L. Accelerated apoptosis in SLE neutrophils cultured with anti-dsDNA antibody isolated from SLE patient serum: A pilot study. Rheumatol. Int. 27, 153\u2013156. https:\/\/doi.org\/10.1007\/s00296-006-0219-z (2006).","journal-title":"Rheumatol. Int."},{"key":"74579_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/01.STR.0000196986.50059.e0","volume":"37","author":"JP Sluijter","year":"2006","unstructured":"Sluijter, J. P. et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: A study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 37, 235\u2013239. https:\/\/doi.org\/10.1161\/01.STR.0000196986.50059.e0 (2006).","journal-title":"Stroke"},{"key":"74579_CR48","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1161\/hc4101.097419","volume":"104","author":"MP Herman","year":"2001","unstructured":"Herman, M. P. et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: A novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104, 1899\u20131904. https:\/\/doi.org\/10.1161\/hc4101.097419 (2001).","journal-title":"Circulation"},{"key":"74579_CR49","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","volume":"103","author":"M Crisby","year":"2001","unstructured":"Crisby, M. et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 103, 926\u2013933 (2001).","journal-title":"Circulation"},{"key":"74579_CR50","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/physiol.00029.2013","volume":"28","author":"A Yabluchanskiy","year":"2013","unstructured":"Yabluchanskiy, A., Ma, Y., Iyer, R. P., Hall, M. E. & Lindsey, M. L. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology 28, 391\u2013403. https:\/\/doi.org\/10.1152\/physiol.00029.2013 (2013).","journal-title":"Physiology"},{"key":"74579_CR51","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1172\/JCI115411","volume":"88","author":"NA Nelken","year":"1991","unstructured":"Nelken, N. A., Coughlin, S. R., Gordon, D. & Wilcox, J. N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Investig. 88, 1121\u20131127. https:\/\/doi.org\/10.1172\/JCI115411 (1991).","journal-title":"J. Clin. Investig."},{"key":"74579_CR52","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.jacc.2007.08.027","volume":"50","author":"NG Frangogiannis","year":"2007","unstructured":"Frangogiannis, N. G. The prognostic value of monocyte chemoattractant protein-1\/CCL2 in acute coronary syndromes. J. Am. Coll. Cardiol. 50, 2125\u20132127. https:\/\/doi.org\/10.1016\/j.jacc.2007.08.027 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"74579_CR53","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/eurheartj\/ehq521","volume":"32","author":"F Montecucco","year":"2011","unstructured":"Montecucco, F. et al. Anti-apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. Eur. Heart. J. 32, 412\u2013421. https:\/\/doi.org\/10.1093\/eurheartj\/ehq521 (2011).","journal-title":"Eur. Heart. J."},{"key":"74579_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514\u2013518. https:\/\/doi.org\/10.1038\/nature07725 (2009).","journal-title":"Nature"},{"key":"74579_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/CIRCULATIONAHA.117.033098","volume":"138","author":"N Paulin","year":"2018","unstructured":"Paulin, N. et al. Double-strand DNA sensing aim2 inflammasome regulates atherosclerotic plaque vulnerability. Circulation 138, 321\u2013323. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033098 (2018).","journal-title":"Circulation"},{"key":"74579_CR56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jaut.2016.06.001","volume":"74","author":"R Lu","year":"2016","unstructured":"Lu, R. et al. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J. Autoimmun. 74, 182\u2013193. https:\/\/doi.org\/10.1016\/j.jaut.2016.06.001 (2016).","journal-title":"J. Autoimmun."},{"key":"74579_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/030097498440859","volume":"27","author":"M Funauchi","year":"1998","unstructured":"Funauchi, M., Ikoma, S., Enomoto, H. & Horiuchi, A. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand. J. Rheumatol. 27, 219\u2013224 (1998).","journal-title":"Scand. J. Rheumatol."},{"key":"74579_CR58","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1521-6616(03)00096-2","volume":"108","author":"B Deocharan","year":"2003","unstructured":"Deocharan, B., Marambio, P., Edelman, M. & Putterman, C. Differential effects of interleukin-4 in peptide induced autoimmunity. Clin. Immunol. 108, 80\u201388 (2003).","journal-title":"Clin. Immunol."},{"key":"74579_CR59","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1172\/JCI119361","volume":"99","author":"SL Peng","year":"1997","unstructured":"Peng, S. L., Moslehi, J. & Craft, J. Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Investig. 99, 1936\u20131946. https:\/\/doi.org\/10.1172\/JCI119361 (1997).","journal-title":"J. Clin. Investig."},{"key":"74579_CR60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/ar3433","volume":"13","author":"T Dorner","year":"2011","unstructured":"Dorner, T., Giesecke, C. & Lipsky, P. E. Mechanisms of B cell autoimmunity in SLE. Arthritis Res. Ther. 13, 243. https:\/\/doi.org\/10.1186\/ar3433 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"74579_CR61","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2016.00520","volume":"7","author":"GM Jogdand","year":"2016","unstructured":"Jogdand, G. M., Mohanty, S. & Devadas, S. Regulators of Tfh cell differentiation. Front. Immunol. 7, 520. https:\/\/doi.org\/10.3389\/fimmu.2016.00520 (2016).","journal-title":"Front. Immunol."},{"key":"74579_CR62","doi-asserted-by":"publisher","first-page":"365083","DOI":"10.1155\/2010\/365083","volume":"2010","author":"DY Yap","year":"2010","unstructured":"Yap, D. Y. & Lai, K. N. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: From basics to recent advances. J. Biomed. Biotechnol. 2010, 365083. https:\/\/doi.org\/10.1155\/2010\/365083 (2010).","journal-title":"J. Biomed. Biotechnol."},{"key":"74579_CR63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","volume":"27","author":"HY Chun","year":"2007","unstructured":"Chun, H. Y. et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J. Clin. Immunol. 27, 461\u2013466. https:\/\/doi.org\/10.1007\/s10875-007-9104-0 (2007).","journal-title":"J. Clin. Immunol."},{"key":"74579_CR64","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/ATVBAHA.115.306983","volume":"36","author":"P Srikakulapu","year":"2016","unstructured":"Srikakulapu, P. et al. Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE\u2212\/\u2212 mice. Arterioscler. Thromb. Vasc. Biol. 36, 1174\u20131185. https:\/\/doi.org\/10.1161\/ATVBAHA.115.306983 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"74579_CR65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/imm.12426","volume":"145","author":"NL Tran","year":"2015","unstructured":"Tran, N. L., Manzin-Lorenzi, C. & Santiago-Raber, M. L. Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism. Immunology 145, 60\u201370. https:\/\/doi.org\/10.1111\/imm.12426 (2015).","journal-title":"Immunology"},{"key":"74579_CR66","doi-asserted-by":"publisher","first-page":"e80743","DOI":"10.1371\/journal.pone.0080743","volume":"8","author":"KJ Brandt","year":"2013","unstructured":"Brandt, K. J., Fickentscher, C., Kruithof, E. K. & de Moerloose, P. TLR2 ligands induce NF-kappaB activation from endosomal compartments of human monocytes. PLoS ONE 8, e80743. https:\/\/doi.org\/10.1371\/journal.pone.0080743 (2013).","journal-title":"PLoS ONE"},{"key":"74579_CR67","doi-asserted-by":"publisher","first-page":"29834","DOI":"10.1038\/srep29834","volume":"6","author":"D Burger","year":"2016","unstructured":"Burger, D., Fickentscher, C., de Moerloose, P. & Brandt, K. J. F-actin dampens NLRP3 inflammasome activity via Flightless-I and LRRFIP2. Sci. Rep. 6, 29834. https:\/\/doi.org\/10.1038\/srep29834 (2016).","journal-title":"Sci. Rep."},{"key":"74579_CR68","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1160\/TH16-02-0139","volume":"116","author":"F Montecucco","year":"2016","unstructured":"Montecucco, F. et al. Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis. Thromb. Haemost. 116, 987\u2013997. https:\/\/doi.org\/10.1160\/TH16-02-0139 (2016).","journal-title":"Thromb. Haemost."},{"key":"74579_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2016.03.013","volume":"94","author":"F Carbone","year":"2016","unstructured":"Carbone, F. et al. Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury. J. Mol. Cell. Cardiol. 94, 82\u201394. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.03.013 (2016).","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74579-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74579-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74579-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:13:38Z","timestamp":1670364818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74579-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74579"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74579-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18324"}}